These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 7970724

  • 41. Secretion of type IV collagenolytic protease and metastatic phenotype: induction by transfection with c-Ha-ras but not c-Ha-ras plus Ad2-E1a.
    Garbisa S, Pozzatti R, Muschel RJ, Saffiotti U, Ballin M, Goldfarb RH, Khoury G, Liotta LA.
    Cancer Res; 1987 Mar 15; 47(6):1523-8. PubMed ID: 3028610
    [Abstract] [Full Text] [Related]

  • 42. Elevated stromelysin-1 and reduced collagenase-IV expression in invasive rat embryo fibroblasts expressing E1A deletion mutants + T24-H-ras.
    Engel G, Popowicz P, Marshall H, Norling G, Svensson C, Auer G, Akusjärvi G, Linder S.
    Int J Cancer; 1992 Jul 09; 51(5):761-6. PubMed ID: 1319410
    [Abstract] [Full Text] [Related]

  • 43. Enhanced ras oncogene mediated cell transformation and tumorigenesis by adenovirus 2 mutants lacking the C-terminal region of E1a protein.
    Subramanian T, La Regina M, Chinnadurai G.
    Oncogene; 1989 Apr 09; 4(4):415-20. PubMed ID: 2524023
    [Abstract] [Full Text] [Related]

  • 44. No acquisition of metastatic capacity of R1H rhabdomyosarcoma upon transfection with c-Ha-ras oncogene.
    Baisch H, Collard J, Zywietz F, Jung H.
    Invasion Metastasis; 1990 Apr 09; 10(4):193-207. PubMed ID: 2192992
    [Abstract] [Full Text] [Related]

  • 45. [Model systems of carcinogenesis in vitro: the interaction of the ras oncogene with immortalized cells].
    Topol' LZ, Spitkovskiĭ DD, Kiselev FL.
    Biull Eksp Biol Med; 1988 Mar 09; 105(3):329-32. PubMed ID: 3280050
    [Abstract] [Full Text] [Related]

  • 46. Search for metastasis suppressor genes.
    Steeg PS.
    Invasion Metastasis; 1989 Mar 09; 9(6):351-9. PubMed ID: 2532185
    [Abstract] [Full Text] [Related]

  • 47. Mr 92,000 gelatinase release correlates with the metastatic phenotype in transformed rat embryo cells.
    Bernhard EJ, Muschel RJ, Hughes EN.
    Cancer Res; 1990 Jul 01; 50(13):3872-7. PubMed ID: 2162246
    [Abstract] [Full Text] [Related]

  • 48. Altered expression of NM23, a gene associated with low tumor metastatic potential, during adenovirus 2 Ela inhibition of experimental metastasis.
    Steeg PS, Bevilacqua G, Pozzatti R, Liotta LA, Sobel ME.
    Cancer Res; 1988 Nov 15; 48(22):6550-4. PubMed ID: 2460224
    [Abstract] [Full Text] [Related]

  • 49. Repression of stromelysin metalloprotease expression in rat fibrosarcoma cells by dimethylsulfoxide.
    Popowicz P, Engel G, Marshall H, Linder S.
    Clin Exp Metastasis; 1993 Jan 15; 11(1):77-82. PubMed ID: 8422709
    [Abstract] [Full Text] [Related]

  • 50. Counter-selection for over-expressed human CD44s in primary tumors versus lung metastases in a mouse fibrosarcoma model.
    Kogerman P, Sy MS, Culp LA.
    Oncogene; 1997 Sep 18; 15(12):1407-16. PubMed ID: 9333016
    [Abstract] [Full Text] [Related]

  • 51. Different patterns of gene expression in ras-resistant and ras-sensitive cells.
    Tuck AB, Wilson SM, Khokha R, Chambers AF.
    J Natl Cancer Inst; 1991 Apr 03; 83(7):485-91. PubMed ID: 1848638
    [Abstract] [Full Text] [Related]

  • 52. Transfection of normal and transformed hamster cerebral cortex glial cells with activated c-H-ras-1 results in the acquisition of a diffusely invasive phenotype.
    Fetherston JD, Cotton JP, Walsh JW, Zimmer SG.
    Oncogene Res; 1989 Apr 03; 5(1):25-30. PubMed ID: 2674858
    [Abstract] [Full Text] [Related]

  • 53. Some immunological properties of high and low tumorigenic cellular variants of c-H-ras transformed 3T3 cells.
    Gonen B, Ran M, Wreschner D, Cahalon L, Anavi R, Shlomo Y, Witz IP.
    Nat Immun Cell Growth Regul; 1988 Apr 03; 7(3):144-54. PubMed ID: 3050475
    [Abstract] [Full Text] [Related]

  • 54. Karyotypic analysis of diploid or near diploid metastatic Harvey ras transformed rat embryo fibroblasts.
    Muschel RJ, Nakahara K, Chu E, Pozzatti R, Liotta LA.
    Cancer Res; 1986 Aug 03; 46(8):4104-8. PubMed ID: 3731077
    [Abstract] [Full Text] [Related]

  • 55. The effect of E1A transfection on MMP-9 expression and metastatic potential.
    Bernhard EJ, Hagner B, Wong C, Lubenski I, Muschel RJ.
    Int J Cancer; 1995 Mar 03; 60(5):718-24. PubMed ID: 7860147
    [Abstract] [Full Text] [Related]

  • 56. Transcriptional activation of fibroblast stromelysin-1 and collagenase gene expression by a novel lymphokine, leukoregulin.
    Mauviel A, Kähäri VM, Chen YQ, Kurkinen M, Evans CH, Uitto J.
    Trans Assoc Am Physicians; 1992 Mar 03; 105():100-9. PubMed ID: 1308987
    [No Abstract] [Full Text] [Related]

  • 57. Phenotypic alterations in fos-transgenic mice correlate with changes in Fos/Jun-dependent collagenase type I expression. Regulation of mouse metalloproteinases by carcinogens, tumor promoters, cAMP, and Fos oncoprotein.
    Gack S, Vallon R, Schaper J, Rüther U, Angel P.
    J Biol Chem; 1994 Apr 08; 269(14):10363-9. PubMed ID: 8144618
    [Abstract] [Full Text] [Related]

  • 58. The cellular response to induction of the p21 c-Ha-ras oncoprotein includes stimulation of jun gene expression.
    Sistonen L, Hölttä E, Mäkelä TP, Keski-Oja J, Alitalo K.
    EMBO J; 1989 Mar 08; 8(3):815-22. PubMed ID: 2498084
    [Abstract] [Full Text] [Related]

  • 59. The reversion of highly tumorigenic cell lines to non-tumorigenic phenotype is associated with c-jun down-expression.
    Lavrovsky Y, Yefremov Y, Lavrovsky V.
    FEBS Lett; 1994 Dec 19; 356(2-3):212-4. PubMed ID: 7805840
    [Abstract] [Full Text] [Related]

  • 60. Oncogenes control stromelysin and collagenase gene expression.
    Butticé G, Kurkinen M.
    Contrib Nephrol; 1994 Dec 19; 107():101-7. PubMed ID: 8004955
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.